Multiple Myeloma: An Overview

Multiple-myeloma, also known as myeloma, is a form of blood cancer that affects plasma cells in the bone marrow.
Ponatinib, sold under the brand name Iclusig, is a third-generation tyrosine kinase inhibitor (TKI) medication used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Multiple-myeloma, also known as myeloma, is a form of blood cancer that affects plasma cells in the bone marrow.